H. O. Onaran And T. Costa, "Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy," BRITISH JOURNAL OF PHARMACOLOGY , no.12, pp.1757-1767, 2024
Onaran, H. O. And Costa, T. 2024. Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy. BRITISH JOURNAL OF PHARMACOLOGY , no.12 , 1757-1767.
Onaran, H. O., & Costa, T., (2024). Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy. BRITISH JOURNAL OF PHARMACOLOGY , no.12, 1757-1767.
Onaran, H., And Tommaso Costa. "Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy," BRITISH JOURNAL OF PHARMACOLOGY , no.12, 1757-1767, 2024
Onaran, H. O. And Costa, Tommaso. "Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy." BRITISH JOURNAL OF PHARMACOLOGY , no.12, pp.1757-1767, 2024
Onaran, H. O. And Costa, T. (2024) . "Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy." BRITISH JOURNAL OF PHARMACOLOGY , no.12, pp.1757-1767.
@article{article, author={H. Ongun Onaran And author={Tommaso Costa}, title={Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy}, journal={BRITISH JOURNAL OF PHARMACOLOGY}, year=2024, pages={1757-1767} }